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Abstract
Background: Accurate detection of Neisseria gonorrhoeae antimicrobial resistance is essential for appropriate
management and prevention of spread of infection in the community. In this study Calibrated Dichotomous
Sensitivity (CDS) and Clinical Laboratory Standards Institute (CLSI) disc diffusion methods were compared with
minimum inhibitory concentration (MIC) by Etest in Neisseria gonorrhoeae isolates from Karachi, Pakistan. CDS and
CLSI disc diffusion techniques, and Etest for ceftriaxone, penicillin G, spectinomycin and ciprofloxacin against 100
isolates from years 2012–2014 were performed. Due to lack of CLSI breakpoints for azithromycin, it was interpreted
using cut-offs from British Society of Antimicrobial Chemotherapy (BSAC). Due to lack of low concentration
tetracycline discs, tetracycline was tested with CLSI disc diffusion and Etest only. Comparisons were based on the
identified susceptibility, intermediate susceptibility and resistance (SIR) categories using the different methods.
Complete percent agreement was percentage agreement achieved when test and reference method had identical
SIR-category. Essential percent agreement was percentage agreement when minor discrepancies were disregarded.
Results: There was 100 % and 99 % overall essential agreement and 50 % versus 23 % overall complete agreement
by CDS and CLSI methods, respectively, with MICs for all tested antibiotics. Using either method, there was 100 %
complete agreement for ceftriaxone and spectinomycin. There was 90 % versus 86 % complete agreement for
ciprofloxacin, and 60 % and 75 % for penicillin using CDS and CLSI method, respectively. Essential agreement of
99 % and complete agreement of 62 % was found for tetracycline with CLSI method. There was 100 % essential
and complete agreement by CDS, BSAC and Etest for azithromycin.
(Continued on next page)
* Correspondence: kauser.jabeen@aku.edu
1Section of Pathology and Laboratory Medicine, Clinical Microbiology Aga
Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan
Full list of author information is available at the end of the article
© 2016 Mal et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Mal et al. BMC Microbiology  (2016) 16:236 
DOI 10.1186/s12866-016-0707-6
(Continued from previous page)
Conclusion: No major errors with regard to identified SIR-categories were found for penicillin, ciprofloxacin,
ceftriaxone and spectinomycin using CLSI and CDS methods. All isolates were susceptible to ceftriaxone and
spectinomycin, and 99 % to azithromycin. In low-resource settings, both the CLSI and CDS disc diffusion techniques
might be used for susceptibility testing of gonococcal isolates. However, these methods require considerable
standardization and quality controls for adequate levels of reproducibility and correct interpretation to reflect
appropriately the MIC values of the different antimicrobials. New, emerging, or rare resistance should be confirmed
by MIC determination.
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Background
Treatment of gonorrhea is compromised due to global
emergence and dissemination of Neisseria gonorrhoeae
strains that are resistant to most antimicrobial agents
available for treatment [1]. Accurate detection of anti-
microbial resistance is essential for appropriate manage-
ment of gonorrhea and prevention of spread of infection
as well as complications in individual patients [2].
There are several methods available for antimicrobial
susceptibility testing in N. gonorrhoeae. These include disc
diffusion methods and/or breakpoints recommended by
the Clinical and Laboratory Standards Institute (CLSI) [3],
British Society for Antimicrobial Chemotherapy (BSAC)
[4] and European Committee on Antimicrobial Suscepti-
bility Testing (EUCAST) [5], and agar dilution and the
Etest techniques that determine the minimum inhibitory
concentration (MIC) of antimicrobials [3]. Many labora-
tories in less-resourced settings use high-content disc dif-
fusion method recommended by the CLSI due to its ease
and low cost. However, disc diffusion method might not
accurately detect all gonococcal strains with decreased
susceptibility or low-level resistance to extended-
spectrum cephalosporins (ESCs) [6]. Calibrated Dichot-
omous Sensitivity method (CDS) using low content disc
diffusion methodology has, in situations when MIC deter-
mination cannot be performed, been advocated by the
World Health Organization (WHO) programs for N.
gonorrhoeae antimicrobial resistance surveillance [7]. Use
of a 30 μg ceftriaxone disc as recommended by the CLSI
has been reported to be ineffective to detect decreased
susceptibility and low-level resistance to ESCs in N. gonor-
rhoeae strains [6]. Therefore use of a ceftriaxone 0.5 μg
disc has been advocated by the CDS-based WHO based
programs for N. gonorrhoeae antimicrobial resistance
surveillance. The lower potency ceftriaxone disc can more
effectively detect increases at the lower MIC values [7]. In
the CDS technique, it was also recently recommended to
additionally use a 10 μg cefpodoxime disc for detection of
decreased susceptibility and resistance to ESCs. The 10 μg
cefpodoxime disc was shown to be an effective screening
method for detection of gonococcal strains containing a
penA mosaic allele encoding a mosaic penicillin-binding
protein 2 (PBP2), which can result in decreased suscepti-
bility or resistance to ESCs [8]. N. gonorrhoeae strains with
decreased susceptibility or resistance to ESCs have not yet
been reported from Pakistan [9]. However, mainly the
CLSI recommended disc diffusion method has been used
and, accordingly, it is essential to appropriately evaluate
this method on the N. gonorrhoeae strains circulating in
Pakistan.
The objective of the present study was to evaluate
the performance of CDS and CLSI disc diffusion tech-
niques in assessing susceptibilities of N. gonorrhoeae to
ceftriaxone, penicillin G, spectinomycin, and ciproflox-
acin. MIC determination using the Etest was applied as
a reference method. Due to the non-availability of low
potency tetracycline discs, tetracycline was compared
using CLSI and reference method only. Furthermore,
azithromycin was tested using BSAC and CDS
methods only as no azithromycin interpretative break-
points are stated by the CLSI. Only two studies have
previously performed a head to head comparison of
the two main disc diffusion methods (CDS and CLSI)
with the Etest [10, 11].
Methods
This prospective descriptive cross-sectional study was
conducted at the Department of Pathology and Labora-
tory Medicine, Aga Khan University Hospital (AKUH),
Karachi, Pakistan. The laboratory is a sentinel site for
surveillance of gonococcal resistance and regularly
participates in international gonococcal external quality
assessment program. One hundred consecutive N.
gonorrhoeae isolates cultured from urethral swabs (n =
85), high vaginal and cervical swabs (n = 14) and con-
junctiva swab (n = 1) from January 2012 to February
2014 were included in the study. The study was ap-
proved by the Ethical Review Committee of university
(Exemption #2365-Pat-12). N. gonorrhoeae isolates were
identified by conventional tests using standard protocol
including colony morphology, Gram staining, oxidase
test, sugar utilization and Remel RapidNH® Panel
(BioMérieux, France).
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Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed and
interpreted according to the CDS [7], CLSI [3], and only
for azithromycin BSAC [4] criteria using disc diffusion
methods, in strict accordance to the instructions from
the manufacturer. Susceptibility with the CLSI method
was performed as routine clinical laboratory work. Iso-
lates were subsequently stored at −80 °C in glycerol buff-
ered phosphate. The isolates were later revived and the
CDS and Etest methods were performed simultaneously
in four batches. MIC determination was performed
using Etest strips as specified by the manufacturer (AB
Biodisk, Stockholm, Sweden) against ceftriaxone, penicil-
lin G, spectinomycin, ciprofloxacin, azithromycin and
tetracycline. Finally, N. gonorrhoeae isolates were also
tested for β-lactamase production by the chromogenic
cephalosporin method using nitrocefin freeze-dried pow-
der (Oxoid, Hampshire, UK).
Inoculum preparation
A homogenous suspension of 0.5 McFarland turbidity was
made from fresh culture (24 h) on GC agar base (GC agar
base medium, Becton Dickinson, UK) with 1 % BBL IsoVi-
talex Enrichment (Becton Dickinson, France). For all four
methods (CLSI, CDS, BSAC and Etest), inoculum was pre-
pared by emulsifying single large or 2–3 small colonies in
2.5 mL sterile saline (0.85 %). This suspension was used
within 15 min. All plates for antimicrobial susceptibility
testing were incubated at 35–37 °C in 5 % CO2-enriched
humid atmosphere for 20-h [3, 7].
CDS disc diffusion method
Due to non-availability of chocolate Columbia agar, anti-
biotic susceptibility testing was performed on GC agar
base (GC agar base medium, Becton Dickinson, UK)
with 1 % BBL IsoVitalex Enrichment (Becton Dickinson,
France) with the following low concentration antibiotic
discs (Oxoid): ceftriaxone (0.5 μg), cefpodoxime (10 μg),
penicillin G (0.5 IU), spectinomycin (100 μg), ciprofloxa-
cin (1 μg), azithromycin (15 μg) and nalidixic acid
(30 μg). The use of this alternate agar medium for sus-
ceptibility testing did not affect the results of the quality
control strains and, accordingly, the results were consid-
ered valid. The results were interpreted by measuring
the annular radius of the inhibition zones and catego-
rized as susceptible (S), intermediate susceptible (I) and
resistant (R) [7]. Cefpodoxime disc (10 μg) was used as
screening method for detection of decreased susceptibil-
ity or resistance to ESC [8]. Nalidixic acid was used as a
marker for detection of isolates with decreased suscepti-
bility to ciprofloxacin. Due to non-availability of low
potency tetracycline discs, CDS disc diffusion technique
was not performed for tetracycline.
CLSI disc diffusion method
Antibiotic susceptibility testing was performed on GC
agar base (GC agar base medium, Becton Dickinson, UK)
with 1 % BBL IsoVitalex Enrichment (Becton Dickinson,
France) with the following high concentration discs
(Oxoid): ceftriaxone (30 μg), penicillin (10 IU), spectino-
mycin (100 μg), ciprofloxacin (5 μg), nalidixic acid (30 μg)
and tetracycline (30 μg). The results were interpreted by
measuring the inhibition zone diameters and categorized
as susceptible, intermediate susceptible and resistant [3].
BSAC disc diffusion method
Antibiotic susceptibility testing for azithromycin (15 μg)
was performed on GC agar base (GC agar base medium,
Becton Dickinson, UK) with 1 % BBL IsoVitalex Enrich-
ment (Becton Dickinson, France). The results were inter-
preted by measuring inhibition zone diameters and
categorized as susceptible, intermediate susceptible or
resistant [4].
Etest method
The Etest method was used as reference method. MICs of
ceftriaxone, penicillin G, spectinomycin, ciprofloxacin, azi-
thromycin and tetracycline were determined by the Etest
method (AB Biodisk), according to manufacturer’s instruc-
tions, on GC agar base (GC agar base medium, Becton
Dickinson, UK) with 1 % BBL IsoVitalex Enrichment
(Becton Dickinson, France). The results were interpreted in
SIR categories according to the CLSI criteria [3].
Quality control strains
N. gonorrhoeae reference strain ATCC 49226 and the
2008 WHO reference strains F, G, K, L, M, N, O, and P
[12] were used as quality controls for the disc diffusion
methods. MICs using the Etest for these strains were
tested against ceftriaxone only (Table 1).
Statistical analysis
Data were analyzed using Stata 12 and Microsoft Excel
2010. The SIR-categories using the CDS and CLSI disk
diffusion methods were compared with the SIR-categories
obtained by the reference method, i.e., the Etest. Rates of
discrepancies for each antibiotic were determined into
three categories minor [test result showed R or S and ref-
erence results showed I or test results showed I and refer-
ence results showed R or S], major (S interpreted as R)
and very major (R interpreted as S) [13].
Complete and essential percent agreement between the
reference and test method was calculated. The complete
percent agreement value was the proportion of isolates
with identical SIR-category by both test and reference
methods. The essential percent agreement value was pro-
portion of isolates with similar results by both reference
and test method when minor errors (as defined above)
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were disregarded [13]. Kappa value was calculated as the
statistical measure of SIR-agreement between reference
(Etest) and evaluated (CLSI or CDS) methods. Kappa
value below zero depicted poor, 0.00–0.20 showed slight
agreement, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80
substantial, and 0.81–1.00 very high agreement.
Results
Antimicrobial susceptibility testing of 100N. gonor-
rhoeae isolates was performed by two disc diffusion
techniques and Etest (reference method) for ceftriaxone,
penicillin G, spectinomycin, ciprofloxacin and tetracyc-
line. The inhibition zone diameters and MICs of the
WHO reference strains (F, G, K, L, M, N, O and P) were
within the acceptable range for these quality control
strains (Table 1). All (100 %) isolates were susceptible to
ceftriaxone and spectinomycin by all three methods.
Using Etest, 99 %, 12 %, 8 % and 0 % isolates were sus-
ceptible to azithromycin, tetracycline, penicillin G and
ciprofloxacin, respectively (Table 2). Table 3 shows com-
parison of discrepancies and agreement of CDS and
CLSI disc diffusion method with Etest as well as kappa
scores for five different antibiotics. The rates of discrep-
ancies for each antibiotic were different for both the
CDS and CLSI technique on comparison with Etest
method as shown in Table 3. An overall essential agree-
ment of 99 % and an overall complete agreement of
23 % were found between CLSI disc diffusion method
and Etest. An overall essential agreement of 100 % and
an overall complete agreement of 50 % were found be-
tween CDS disc diffusion method and Etest. Statistically
kappa scores for penicillin G showed that CDS method
had fair while CLSI method had moderate level of agree-
ment with Etest. For ciprofloxacin, CDS method had
moderate agreement while CLSI method had slight
agreement with Etest. For tetracycline, CLSI method had
fair level of agreement (Table 3). For ceftriaxone and
spectinomycin; kappa value could not be calculated be-
cause there was only one category i.e. susceptible. Ac-
cordingly, the complete percent agreement of the CDS
and CLSI method with Etest for ceftriaxone and spec-
tinomycin was 100 %.
Table 4 shows SIR agreement rates for penicillin, azi-
thromycin and ciprofloxacin using CDS method and
Table 1 Mean annular radius and expected ranges of WHO Neisseria gonorrhoeae reference strains (F, G, K, L, M, N, O and P)
Methods Antibiotics tested F G K L M N O P
CDS Penicillin G Mean annular
radius (range)
13.2 (12–15) 5.5 (3–7) 00 00 00 00 00 6 (5–7)
Expected
result
>9 (S) 3–9 (I) <3 (R) <3 (R) <3 (R) <3 (R) <3 (R) 3–9 (I)
β-lactamase
production
No No No No Yes Yes Yes No
Expected
result
No No No No Yes Yes Yes No
Ciprofloxacin Mean annular
radius (range)
15 (14–17) 7.7 (7–9) 00 00 3.2 (02–4) 00 13.5 (12–15) 14.2 (13–16)
Expected
result
≥11 (S) 6–10 (I) <6 (R) <6 (R) <6 (R) <6 (R) ≥11 (S) ≥11 (S)
Spectinomycin Mean annular
radius (range)
11 (10–11) 10.2 (9–11) 16 (15–18) 9.5 (8–11) 11 (9–13) 13.5 (10–17) 00 13 (11–15)
Expected
result
≥6 (S) ≥6 (S) ≥6 (S) ≥6 (S) ≥6 (S) ≥6 (S) <6 (R) ≥6 (S)
Azithromycin Mean annular
radius (range)
12.5 (10–15) 14 (12–16) 13.5 (12–
15)
11 (9–13) 12 (9–15) 11.5 (10–13) 13 (12–15) 1.5 (0–4)
Expected
result
≥8 (S) ≥8 (S) ≥8 (S) ≥8 (S) ≥8 (S) ≥8 (S) ≥8 (S) <8 (R)
Ceftriaxone Mean annular
radius (range)
14.2 (12–16) 14.7 (14–16) 6.7 (6–8) 5.5 (5–7) 13 (12–15) 13.2 (12–15) 13.2 (13–15) 13.7 (13–15)
Expected
result
≥10 (S) ≥10 (S) 5–9 (DS) 5–9 (DS) ≥10 (S) ≥10 (S) ≥10 (S) ≥10 (S)
MIC by
Etest
Ceftriaxonea Etest MIC
ranges
<0.002 0.004–0.008 0.064–0.125 0.125–0.25 0.008–0.016 0.002–0.004 0.016–0.032 0.004–0.008
Expected
result
<0.002
(S)
0.004–0.016
(S)
0.032–0.125
(DS)
0.064–0.25
(DS)
0.008–0.032
(S)
0.002–0.008
(S)
0.016–0.064
(S)
0.002–0.008
(S)
aMICs for control strains was performed only for ceftriaxone. DS Decreased susceptibility, S Sensitive, I intermediate, R resistant
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penicillin, tetracycline, azithromycin and ciprofloxacin
using CLSI method against reference method. This table
also describes the number of concordant and discordant
results using these two methods. Majority of discordant
results were seen with penicillin using both methods
and with tetracycline using CLSI method. Ciprofloxacin
discordance rates were comparable by both CDS and
CLSI methods. The details of each antibiotic results are
discussed separately below.
Penicillin G
By the Etest, 08 %, 49 % and 43 % of isolates were inter-
preted as susceptible, intermediate susceptible and re-
sistant, respectively (Table 2). Of 43 penicillin G
resistant isolates, 41 were β-lactamase positive and two
had chromosomally mediated resistance. On comparison
of Etest with CDS and CLSI disc diffusion methods,
minor discrepancies were observed at 40 % and 25 %, re-
spectively (Table 3; details of discordance are shown in
Table 4). Major and very major discrepancies were not
found with any of the disc diffusion methods. The
complete percent agreement of the CDS and CLSI
method with Etest for penicillin G was 60 % and 75 %
respectively, and the essential agreement was 100 %.
Ciprofloxacin
None of the isolates were susceptible to ciprofloxacin by
Etest. The number of intermediate susceptible and re-
sistant isolates were 14 (14 %) and 86 (86 %), respect-
ively (Table 3). Out of 86 resistant isolates, 48 (55.8 %)
had a high-level resistance (defined as MIC ≥4 μg/ml).
On comparison of Etest with CDS and CLSI disc diffu-
sion methods, minor discrepancies were observed at
10 % and 14 %, respectively (Tables 3, 4). Complete
agreement for the CDS and CLSI method was 90 % and
86 %, respectively. No major and very major discrepan-
cies were observed.
Table 3 Comparison of discrepancies and agreement between the CDS, CLSI and Etest method for 100 Neisseria gonorrhoeae
isolates
Antibiotics No. of discrepancies % Agreement Kappa value
Minor Major Very major Complete Essential
Methods CDS CLSI CDS CLSI CDS CLSI CDS CLSI CDS CLSI CLSI CDS
Ceftriaxone 00 00 00 00 00 00 100 100 100 100 - -
Spectinomycin 00 00 00 00 00 00 100 100 100 100 - -
Penicillin G 40 25 00 00 00 00 60 75 100 100 0.5652 0.3435
Ciprofloxacin 10 14 00 00 00 00 90 86 100 100 0.0990 0.6718
Tetracycline -a 37 -a 01 -a 00 -a 62 -a 99 0.2963 -a
Overall 50 76 00 01 00 00 50 23 100 99 - -
aNot tested
Minor error: test result showed resistant or susceptible and reference results showed intermediate or test results showed intermediate and reference results
showed resistant or susceptible
Major error: test result showed susceptible and reference results showed resistant
Very major error: test result showed resistant and reference results susceptible
Complete percent agreement value was percentage agreement achieved when the test and reference method had identical SIR-category of result
Essential percent agreement value was percentage agreement obtained between the reference and test method when minor discrepancies were disregarded
Table 2 Antimicrobial susceptibility results of Neisseria gonorrhoeae isolates by CDS/CLSI disc diffusion and MIC by Etest (n = 100)
Methods Penicillin G % Ciprofloxacin % Ceftriaxone % Tetracycline % Spectinomycin % Azithromycin %
S I R S I R S I R S I R S I R S I R
Etest MIC 08 49 43 00 14 86 100 00 00 12 37 51 100 00 00 99 00 01
CLSI/BSACa MIC
break points (μg/ml)
≤0.06 0.12-1 ≥2 ≤0.06 0.12-0.5 ≥1 ≤0.25 - - ≤0.25 0.5–1 ≥2 ≤32 64 ≥128 ≤0.25 0.5 ≥0.5
CDS disc diffusion 10 13 77 00 20 80 100 00 00 NP NP NP 100 00 00 99 00 01
CDS annular radius
break points (mm)
>9 3-9 <3 ≥11 6-10 <6 ≥10 - 5-9 NP NP NP ≥6 - <6 ≥8 - <8
CLSI disc diffusion 04 34 62 00 04 96 100 00 00 03 40 57 100 00 00 99 00 01
CLSI/BSACa zone
diameter break points (mm)
≥47 27-46 ≤26 >41 28-40 ≤27 ≥35 - - ≥38 31-37 <30 ≥18 15-17 ≤4 ≥28 - ≤27
S sensitive, I intermediate, R resistant
NP not performed
aBSAC breakpoints were used for Azithromycin
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Tetracycline
By Etest 12 %, 37 % and 51 % of isolates were inter-
preted as susceptible, intermediate susceptible and re-
sistant, respectively (Table 2). Out of 51 resistant
isolates, 28(54.9 %) were tetracycline resistant N. gonor-
rhoeae (TRNG) (MIC ≥16 μg/ml). On comparison of the
CLSI disc diffusion technique with the Etest, 1 % major
and 37 % minor discrepancies were found (Table 3). The
complete and essential percentage agreement for the
CLSI technique was 62 % and 99 %, respectively.
Azithromycin
Ninety-nine percent and 01 % of isolates were inter-
preted as susceptible and resistant, respectively, by the
Etest, BSAC and CDS disc diffusion methods (Table 2).
100 % complete agreement and essential agreement were
found for both the BSAC and CDS method when com-
pared with the Etest.
Discussion
Present study reports a head to head comparison of the
CLSI and CDS disc diffusion methods with the Etest
(MIC-based reference method) for antimicrobial suscep-
tibility testing of N. gonorrhoeae. A poor overall agree-
ment (23 %) between the CLSI disc diffusion method
and the Etest was seen. Discrepancies were most fre-
quent for tetracycline, where 37 minor errors and 1
major error were noted with a complete agreement of
62 % with the Etest. These results are concordant with
findings of Singh et al. from India, where an overall
agreement of 49.5 % was reported between the CLSI
method and reference method [10]. In this previous
study [10] also, one of the main reason of the poor per-
formance of the CLSI method was the low agreement
for tetracycline (75 %) with the reference method. When
excluding tetracycline from the analysis, the overall
agreement of the CLSI method with the reference
method increased from 23 % to 61 % in our study and to
49.5 % to 75 % in the study by Singh et al. [10]. In con-
trast, Khaki et al. reported excellent agreement of the
CLSI method with the reference method [11].
In the current study, an overall agreement of 50 % was
found between the CDS method and the reference
method. Singh et al. reported an overall agreement of
82 % between CDS method and the reference method
[10]. Khaki et al. also reported excellent agreement of
CDS with the reference method [11]. We could not
compare our results with these studies because we did
not perform CDS testing of tetracycline due to non-
availability of low concentration tetracycline discs.
Our findings for ceftriaxone and spectinomycin were
consistent with those of Singh et al. who reported 100 %
complete agreement of spectinomycin by both methods
and 98.6 % complete agreement of ceftriaxone by CLSI
and 98.3 % by CDS technique [10]. Khaki et al. reported
100 % complete agreement of both the CDS and CLSI
methods and the reference method for spectinomycin
and ceftriaxone [11]. For penicillin G higher proportion
of isolates were labeled as resistant by the CDS method
in comparison to reference method. These results were
similar to Khaki et al. who also reported that the CDS
method interpreted intermediate isolates as resistant to
penicillin [11]. Bala et al. reported moderate level of
agreement between the CDS method and reference
method for penicillin, that is, 28 % minor errors by the
CDS method [14].
For ciprofloxacin our results are consistent with Singh
et al. and Bala et al. Accordingly, Singh et al. reported a
complete agreement of 88.5 % for the CLSI method and
92.9 % for the CDS method with reference method and
Table 4 SIR agreement rate of Neisseria gonorrhoeae isolates by
CDS/CLSI disc diffusion against MIC by Etest (All 100 isolates
were sensitive to ceftriaxone and spectinomycin by all three
methods therefore are not shown in this table)
Category Etest Complete agreement
Concordant
results
Discordant
Results
S I R
CDS
Penicillin G S 06 04 00 60 40
I 02 11 00
R 00 34 43
Ciprofloxacin S 00 00 00 90 10
I 00 12 08
R 00 02 78
Azithromycin S 99 00 00 100 00
I 00 00 00
R 00 00 01
CLSI
Penicillin G S 04 00 00 75 25
I 04 29 01
R 00 20 42
Ciprofloxacin S 00 00 00 86 14
I 00 02 02
R 00 12 84
Tetracycline S 01 02 00 62 37
I 10 20 10
R 01 15 41
Azithromycina S 99 00 00 100 00
I 00 00 00
R 00 00 01
SIR: Sensitive, intermediate, resistant
Tetracycline was tested with CLSI method only
aBSAC break points were used for Azithromycin
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Bala et al. reported a complete agreement of 79.8 % for
the CDS method with reference method [10, 14]. In con-
trast, Khaki et al. reported 100 % agreement by both
methods [11].
No discrepancy was observed for azithromycin be-
tween the CDS, BSAC and reference methods. Due to
the lack of azithromycin SIR break-points stated by the
CLSI, the CLSI method was not evaluated for this anti-
microbial in the current study or previous studies by
Singh et al. and Bala et al. [10, 14].
The current study observed an overall essential agree-
ment of 100 % and 99 % with CDS and CLSI technique,
respectively, with the reference method. Only one isolate
showed a major error in the tetracycline reporting by the
CLSI method in current study. In contrast, Singh et al. re-
ported 16 major errors by CLSI method in tetracycline
reporting and 2 major errors by CDS method [10].
In less-resourced settings, where the preferred MIC-
testing cannot be performed, Singh et al. reported that
the CDS disc diffusion method was preferred to the
CLSI disc diffusion method for antimicrobial susceptibil-
ity testing of N. gonorrhoeae [10]. However, Khaki et al.
recommended the CLSI method because it was more ac-
curate and more feasible compared to the CDS method.
In the current study, no major errors were identified for
penicillin G, ciprofloxacin, ceftriaxone and spectino-
mycin testing by any of the methods.
Limitations
Low concentration disc for tetracycline was not tested so
its comparison with CDS method was not possible. Rec-
ommended media like Columbia agar for CDS and 5 %
defibrinated horse blood agar for BSAC methods were not
used due to non-availability of these media. However the
techniques were optimized on the media used in current
study by using WHO quality control strains for CDS tech-
nique and ATCC 49226 for BSAC technique. Since 100 %
of investigated isolates were susceptible to ceftriaxone and
spectinomycin, and 99 % to azithromycin, agreement
across all categories could not be assessed.
Conclusion
In less-resourced settings, both the CLSI and CDS disc dif-
fusion techniques might be used for susceptibility testing of
gonococcal isolates. However results of disc diffusion
methods for tetracycline and for isolates approaching SIR
breakpoints for ceftriaxone, spectinomycin and azithromy-
cin should be interpreted with caution. Furthermore, the
disc diffusion methods require considerable standardization
and appropriate quality control measures to attain an ad-
equate level of reproducibility and correct interpretation,
reflecting the MIC values of the different antimicrobials.
New, emerging, or rare resistance should always be
confirmed by MIC determination. Finally, due to the non-
availability of low antimicrobial concentration discs in the
country a wide implementation of CDS disc diffusion
method in Pakistan could be challenging.
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